[Core-binding factor alpha1 gene modified marrow mesenchymal stem cells for repairing radial defects]

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Surgery

Background:

• Bone defects present significant clinical challenges.
• Mesenchymal stem cells (MSCs) and acellular bone extracellular matrix (ECM) are promising for bone regeneration.
• Gene modification of MSCs can enhance their therapeutic potential.

Purpose of the Study:

• To evaluate the feasibility of using Cbfal gene-modified MSCs with porcine acellular bone ECM for radial defect repair.
• To assess the efficacy of this combination in promoting bone healing in a rabbit model.

Main Methods:

• Radial defects were created in rabbits and treated with Cbfal gene-modified MSCs/ECM complexes (Group A).
• Control groups received unmodified MSCs/ECM (Group B), acellular ECM alone (Group C), or no treatment (Group D).
• Macroscopic, X-ray, histological, and biomechanical analyses were performed at various time points.

Main Results:

• Group A demonstrated mature new bone formation, complete remodeling, and marrow cavity rebuilding by 12 weeks.
• Cbfal gene-modified MSCs/ECM significantly outperformed control groups in bone healing and regeneration.
• Biomechanical testing showed no significant difference in compression loading between Groups A, B, and D, but Group C showed significant differences compared to D.

Conclusions:

• Cbfal gene-modified MSCs combined with acellular bone ECM are effective in repairing rabbit radial defects.
• This strategy holds potential for advancing bone defect regeneration therapies.
• Further research is warranted to explore clinical applications.